NIH Guide: Weekly Index for January 13, 2023

Funding Opportunities

• Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
  (PAR-22-261)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
• Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
  (PAR-23-060)
  National Institute of Mental Health
  Application Receipt Date(s): January 9, 2026
• Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
  (PAR-23-061)
  National Institute of Mental Health
  Application Receipt Date(s): January 9, 2026
• Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
  (PAR-23-062)
  National Institute of Mental Health
  Application Receipt Date(s): January 9, 2026
• NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
  (PAR-23-064)
  National Institute on Drug Abuse
  Application Receipt Date(s): January 7, 2026
• NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
  (PAR-23-070)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is February 12, 2023. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
  (PAR-23-071)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is, February 12, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed)
  (PAR-23-073)
  National Institute of Allergy and Infectious Diseases
  National Institute on Aging
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): January 7, 2026
• In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
  (PAR-23-074)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
  (PAR-23-076)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
  (PAR-23-082)
  National Institute on Aging
  Application Receipt Date(s): December 9, 2024
• Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
  (PAR-23-084)
  National Institute of Allergy and Infectious Diseases
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
  (PAR-23-087)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
  (PAR-23-101)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
  (PAR-23-102)
  National Institute of Mental Health
  National Institute of Mental Health
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required )
  (PAR-23-103)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required)
  (PAR-23-104)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
  (PAR-23-105)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)
  (RFA-AG-24-001)
  National Institute on Aging
  Application Receipt Date(s): September 26, 2025
• Renewal of the Interventions Testing Program (U01 Clinical Trial Not Allowed)
  (RFA-AG-24-002)
  National Institute on Aging
  Application Receipt Date(s): July 6, 2023
• Interventions Testing Program (ITP) Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-AG-24-003)
  National Institute on Aging
  Application Receipt Date(s): June 19, 2023
• Planning for the TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (R34 Clinical Trial Not Allowed)
  (RFA-DE-23-014)
  National Institute of Dental and Craniofacial Research
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Food and Drug Administration
  Application Receipt Date(s): April 14, 2023
• Accelerating Data and Metadata Standards in the Environmental Health Sciences (R24 Clinical Trial Not Allowed)
  (RFA-ES-23-002)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): May 10, 2023
• Pediatric Heart Network Clinical Research Centers (UM1 Clinical Trial Optional)
  (RFA-HL-24-001)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): May 12, 2023
• Limited Competition: Pediatric Heart Network for the Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-HL-24-002)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): May 12, 2023
• Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Coordination Center (U24 Clinical Trial Not Allowed)
  (RFA-HL-24-003)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): March 10, 2023
• Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed)
  (RFA-HL-24-004)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): March 10, 2023
• Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required)
  (RFA-MH-23-170)
  National Institute of Mental Health
  Application Receipt Date(s): February 22, 2023
• Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
  (RFA-NS-23-012)
  National Institute of Neurological Disorders and Stroke
  Office of the Director, NIH
  Application Receipt Date(s): March 23, 2023
• Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed)
  (RFA-OD-23-001)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.